Works by Kim, Richard D.

Results: 29
    1
    2
    3

    Pretreatment CT and PET radiomics predicting rectal cancer patients in response to neoadjuvant chemoradiotherapy.

    Published in:
    Reports of Practical Oncology & Radiotherapy, 2021, v. 26, n. 1, p. 29, doi. 10.5603/RPOR.a2021.0004
    By:
    • Zhigang Yuan;
    • Frazer, Marissa;
    • Rishi, Anupam;
    • Latifi, Kujtim;
    • Tomaszewski, Michal R.;
    • Moros, Eduardo G.;
    • Feygelman, Vladimir;
    • Felder, Seth;
    • Sanchez, Julian;
    • Dessureault, Sophie;
    • Imanirad, Iman;
    • Kim, Richard D.;
    • Harrison, Louis B.;
    • Hoffe, Sarah E.;
    • Zhang, Geoffrey G.;
    • Frakes, Jessica M.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Metagenomics and chemotherapy‐induced nausea: A roadmap for future research.

    Published in:
    Cancer (0008543X), 2022, v. 128, n. 3, p. 461, doi. 10.1002/cncr.33892
    By:
    • Crowder, Sylvia L.;
    • Hoogland, Aasha I.;
    • Welniak, Taylor L.;
    • LaFranchise, Elizabeth A.;
    • Carpenter, Kristen M.;
    • Li, Daneng;
    • Rotroff, Daniel M.;
    • Mariam, Arshiya;
    • Pierce, Christine M.;
    • Fischer, Stacy M.;
    • Kinney, Anita Y.;
    • Dong‐Binh Tran, Thi;
    • Rastegari, Farzaneh;
    • Berry, Donna L.;
    • Extermann, Martine;
    • Kim, Richard D.;
    • Tometich, Danielle B.;
    • Figueiredo, Jane C.;
    • Muzaffar, Jameel;
    • Bari, Shahla
    Publication type:
    Article
    15
    16
    17

    Multicenter, randomized, double‐blind phase 2 trial of FOLFIRI with regorafenib or placebo as second‐line therapy for metastatic colorectal cancer.

    Published in:
    Cancer (0008543X), 2018, v. 124, n. 15, p. 3118, doi. 10.1002/cncr.31552
    By:
    • Sanoff, Hanna K.;
    • Goldberg, Richard M.;
    • Ivanova, Anastasia;
    • O'Reilly, Seamus;
    • Kasbari, Samer S.;
    • Kim, Richard D.;
    • McDermott, Ray;
    • Moore, Dominic T.;
    • Zamboni, William;
    • Grogan, William;
    • Cohn, Allen Lee;
    • Bekaii‐Saab, Tanios S.;
    • Leonard, Gregory;
    • Ryan, Theresa;
    • Olowokure, Olugbenga O.;
    • Fernando, Nishan H.;
    • McCaffrey, John;
    • El‐Rayes, Bassel F.;
    • Horgan, Anne M.;
    • Sherrill, Gary Bradley
    Publication type:
    Article
    18

    Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancer.

    Published in:
    2018
    By:
    • Sanoff, Hanna K;
    • Goldberg, Richard M;
    • Ivanova, Anastasia;
    • O'Reilly, Seamus;
    • Kasbari, Samer S;
    • Kim, Richard D;
    • McDermott, Ray;
    • Moore, Dominic T;
    • Zamboni, William;
    • Grogan, William;
    • Cohn, Allen Lee;
    • Bekaii-Saab, Tanios S;
    • Leonard, Gregory;
    • Ryan, Theresa;
    • Olowokure, Olugbenga O;
    • Fernando, Nishan H;
    • McCaffrey, John;
    • El-Rayes, Bassel F;
    • Horgan, Anne M;
    • Sherrill, Gary Bradley
    Publication type:
    journal article
    19
    20
    21
    22
    23

    Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy.

    Published in:
    Cancers, 2025, v. 17, n. 11, p. 1797, doi. 10.3390/cancers17111797
    By:
    • Yu, James;
    • Laborde, Jose M.;
    • Park, Robin;
    • Shahzad, Moazzam;
    • Kim, Youngchul;
    • Cheon, Jaekyung;
    • Imanirad, Iman;
    • Kim, Richard D.;
    • Biachi de Castria, Tiago;
    • Nardella, Nicole L.;
    • Malafa, Mokenge;
    • Denbo, Jason W.;
    • Fleming, Jason B.;
    • Hoffe, Sarah E.;
    • Frakes, Jessica M.;
    • Sinnamon, Andrew J.;
    • Pimiento, Jose M.;
    • Hodul, Pamela J.;
    • Kim, Dae Won
    Publication type:
    Article
    24
    25
    26
    27
    28
    29